Article Details

Greenwich LifeSciences Publishes Additional Positive Safety Data from GP2 Phase IIb Trial at ...

Retrieved on: 2021-06-07 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

Greenwich LifeSciences Publishes Additional Positive Safety Data from GP2 Phase IIb Trial at .... View article details on HISWAI: https://www.citizentribune.com/news/business/greenwich-lifesciences-publishes-additional-positive-safety-data-from-gp2-phase-iib-trial-at-asco-2021/article_d3e9b881-4ebb-529b-a436-02299957e024.html

Excerpt

STAFFORD, Texas--(BUSINESS WIRE)--Jun 7, 2021--. Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage ...

Article found on: www.citizentribune.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up